Allurion, a Boston-based startup offering a non-invasive gastric balloon by swallowing a pill, has gained $27 million in Series C funding from previous investor Romulus Capital, with new participation from Cogepa Investments and IDO Investments, an innovation firm based in Oman. Read More on Tech Crunch
Gastric bypass surgery in a pill startup Allurion gets $27 million as it pursues FDA approval
About the Author: Gizmo News
Gizmo News brings you the latest buzz about Gizmos, Gadgets and Tech Gifts. If you want to keep up just check Gizmo News.